IR-Med Company Description
IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications.
The company’s development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children.
IR-Med Inc. is headquartered in Rosh Pinna, Israel.
Country | United States |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 4 |
CEO | Ran Ziskind |
Contact Details
Address: ZHR Industrial Zone Rosh Pinna, Nevada 1231400 Israel | |
Phone | 972 4 655 5054 |
Website | ir-medical.com |
Stock Details
Ticker Symbol | IRME |
Exchange | OTCMKTS |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | US46265R1032 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Ran Ziskind | Chief Executive Officer |
Oded Bashan | Co-Founder and Chairman |
Aharon Klein | Co-Founder, Chief Technology Officer and Director |
Aharon Binur | Chief Development Officer |
Dr. Yaniv Cohen M.Sc., Ph.D. | Co-Founder, Chief Scientific Officer and Director |
Sharon Levkoviz | Chief Financial Officer, Treasurer and Secretary |